Gene · 54890
Papers4,144
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 4,144
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| m6A methyltransferase METTL16 mediates immune evasion of colorectal cancer cells via epigenetically regulating PD-L1 expression. | Aging (Albany NY) | 2023 | 37647025 | PubTator, text mining | PubMed |
| The ALKBH5/SOX4 axis promotes liver cancer stem cell properties via activating the SHH signaling pathway. | J Cancer Res Clin Oncol | 2023 | 37646828 | PubTator, text mining | PubMed |
| FOXO1 regulates osteogenic differentiation of periodontal ligament stem cells through the METTL3 signaling pathway. | J Orthop Surg Res | 2023 | 37644500 | PubTator, text mining | PubMed |
| Deciphering RNA m6 A regulation in aging: Perspectives on current advances and future directions. | Aging Cell | 2023 | 37641471 | PubTator, text mining | PubMed |
| RBFOX2 recognizes N6-methyladenosine to suppress transcription and block myeloid leukaemia differentiation. | Nat Cell Biol | 2023 | 37640841 | PubTator, text mining | PubMed |
| The involvement of MALAT1-ALKBH5 signaling axis into proliferation and metastasis of human papillomavirus-positive cervical cancer. | Cancer Biol Ther | 2023 | 37639643 | PubTator, text mining | PubMed |
| YTHDC2 inhibits rat bone mesenchymal stem cells osteogenic differentiation by accelerating RUNX2 mRNA degradation via m6A methylation. | Heliyon | 2023 | 37636387 | PubTator, text mining | PubMed |
| Prognosis analysis and validation of lipid metabolism-associated lncRNAs and tumor immune microenvironment in bladder cancer. | Aging (Albany NY) | 2023 | 37632832 | PubTator, text mining | PubMed |
| Changes in m6A in Steatotic Liver Disease. | Genes (Basel) | 2023 | 37628704 | PubTator, text mining | PubMed |
| The 3' Non-Coding Sequence Negatively Regulates PD-L1 Expression, and Its Regulators Are Systematically Identified in Pan-Cancer. | Genes (Basel) | 2023 | 37628671 | PubTator, text mining | PubMed |
| The Spectrum of Molecular Pathways in Gliomas-An Up-to-Date Review. | Biomedicines | 2023 | 37626776 | PubTator, text mining | PubMed |
| The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and ERK signaling. | Cell Death Dis | 2023 | 37626050 | PubTator, text mining | PubMed |
| Methylation across the central dogma in health and diseases: new therapeutic strategies. | Signal Transduct Target Ther | 2023 | 37620312 | PubTator, text mining | PubMed |
| FOXM1 maintains fatty acid homoeostasis through the SET7-H3K4me1-FASN axis. | Cell Death Discov | 2023 | 37620304 | PubTator, text mining | PubMed |
| The hidden RNA code: implications of the RNA epitranscriptome in the context of viral infections. | Front Genet | 2023 | 37614818 | PubTator, text mining | PubMed |
| Hypoxia-induced cancer cell reprogramming: a review on how cancer stem cells arise. | Front Oncol | 2023 | 37614497 | PubTator, text mining | PubMed |
| RNA modification: mechanisms and therapeutic targets. | Mol Biomed | 2023 | 37612540 | PubTator, text mining | PubMed |
| M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription. | Oncogene | 2023 | 37612524 | PubTator, text mining | PubMed |
| ALKBH5 promotes hypopharyngeal squamous cell carcinoma apoptosis by targeting TLR2 in a YTHDF1/IGF2BP2-mediated manner. | Cell Death Discov | 2023 | 37612282 | PubTator, text mining | PubMed |
| Characterization of m6A modifiers and RNA modifications in uterine fibroids. | bioRxiv | 2023 | 37609293 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54890/papers?page=43